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Nicotine Keeps Leaf-Loving 
Herbivores at Bay
DOI: 10.1371/journal.pbio.0020250
Sooner or later, a gardener looking for 
“nontoxic” ways to control the inevitable 
attack on a favorite plant will discover 
the nicotine remedy. Steep a cup of 
loose tobacco in a gallon of water, let 
it sit overnight, strain, and spray away. 
Caterpillars, aphids, and a diverse array of 
insects predisposed to devouring plants 
will soon abandon your vegetables and 
ﬂ  owers in search of less disagreeable 
forage. 
The ultimate sitting duck, plants rely 
on an arsenal of chemical metabolites 
to fend off predators. Many of these 
chemicals harbor anti-herbivore 
properties, which have been 
exploited for commercial 
use. Nicotine, it turns out, is 
so toxic that it was one of 
the ﬁ  rst chemicals used in 
agricultural insecticides. It’s 
not clear, though, whether 
these toxic metabolites are 
really defending plants against 
hungry herbivores in their 
natural environment, especially 
since many insects can tolerate 
various plant chemicals and 
sometimes even incorporate 
them into their own defenses. 
Though scientists have 
cataloged a long list of these 
presumed resistance traits, 
there’s no evidence that they offer plants 
a competitive advantage against their 
leaf-covetous foes in nature. 
With plant and plant-eater engaged in 
an ever-escalating battle of evolutionary 
one-upmanship and with plants capable 
of producing an array of defensive 
responses, teasing out the predator-
resistant effects of individual plant 
metabolites has proved challenging. 
Theoretically, one could track down 
a resistance gene by breeding plants 
that are genetically identical save for 
the gene that controls expression of a 
particular resistance trait. In practice, 
however, traditional breeding techniques 
aren’t that precise and tend to generate 
additional variations in genomic regions 
that are linked to the target gene and 
that might affect resistance as well.
The tools of genetic engineering 
have largely overcome such limitations, 
allowing scientists far greater control 
and speciﬁ  city. Following this approach, 
Ian Baldwin and colleagues use 
transgenic silencing (which introduces 
gene “constructs” into an organism 
to inactivate a gene of interest) to 
investigate a single resistance trait, 
nicotine production. Even though 
nicotine is one of the best-studied 
putative resistance traits, its speciﬁ  c role 
has been unclear. 
To isolate the resistance effects of 
nicotine from possible confounding 
factors, Baldwin and colleagues blocked 
nicotine production in the Nicotiana 
attenuata tobacco plant. Focusing on 
an enzyme, called putrescine methyl 
transferase (PMT), central to nicotine 
biosynthesis, the authors used two 
techniques that interfere with PMT 
production by silencing the gene, 
pmt, that encodes the enzyme. One of 
the techniques (which adds genetic 
sequences called “inverted repeats” 
to gene fragments) proved far more 
effective at silencing pmt, producing 29 
out of 34 plant lines with only 3%–4% of 
normal nicotine levels.
With suitably nicotine-deprived plants, 
Baldwin and colleagues could directly 
test nicotine’s role in tobacco ﬁ  tness. They 
transplanted the transgenic plants, along 
with nonmutant cultivated plants, in 
southwestern Utah, N. attenuata’s native 
habitat. A subset of the plants was also 
treated with a chemical known to increase 
both nicotine content and resistance to 
herbivore attack. Predictably, several of the 
plant’s natural insect enemies made an 
appearance. Untreated nicotine-deﬁ  cient 
transgenic plants fared the worst, losing 
twice as much foliage to herbivores 
as nonmutant plants. Transgenic 
plants treated with the chemical boost 
performed much better, showing about 
the same amount of damage as the 
nonmutants. Interestingly, tobacco 
hornworms—which, as their name implies, 
feed primarily on tobacco—preferred 
nicotine-free plants when given the 
choice. Though the worms have 
evolved strategies for coping 
with nicotine’s deleterious 
effects, these adaptations come 
at a price: worms feeding on 
nicotine-deﬁ  cient tobacco 
grew bigger and faster than 
those feeding on plants with 
normal nicotine levels. 
These results clearly show 
that nicotine protects tobacco 
plants in their native habitat, 
the authors conclude, and 
that tobacco-chewing insects 
“prefer low nicotine diets.” 
Removing nicotine from the 
equation reveals the relentless 
pressure that plants face from 
herbivores. Without such defenses, plants 
would be unceremoniously eliminated 
posthaste, leaving a world without 
greenery, not to mention oxygen. But 
these experiments also demonstrate 
the unprecedented power of transgenic 
tools to peel back the obfuscating layers 
inherent in ecological interactions to 
reveal the fundamental properties of 
those interactions. And that scientists 
working to unravel the tangled web of 
ecological interactions would do well to 
take advantage of the longest running 
experiment on earth—the natural 
environment.
Steppuhn A, Gase K, Krock B, Halitschke 
R, Baldwin IT (2004) Nicotine’s defensive 
function in nature. DOI: 10.1371/journal.
pbio.0020217
DOI: 10.1371/journal.pbio.0020250.g001
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Deconstructing Genetic Contributions to Autoimmunity 
in Mouse Models
DOI: 10.1371/journal.pbio.0020220
Given the overwhelming complexity of the immune system, it’s no wonder that 
unraveling the mechanisms responsible for immunological disease has proved so 
difﬁ  cult. The factors that trigger autoimmunity—which involves a breakdown in the 
body’s ability to tolerate its own molecules—are not well understood, though animal 
studies show that genetic predisposition greatly increases risk. And that’s where the 
real challenge begins. For certain diseases, individuals with defects in both copies of a 
speciﬁ  c gene invariably develop the disease. But more often, diseases with an inherited 
component result from the complex interplay of a variety of genes, each contributing 
a small effect that is typically dependent both on the expression of other genes and on 
both random and environmental factors. 
Researchers have increasingly turned to mice to model autoimmunity in humans and 
have found the same genetic complexity at work, with different strains of lupus-prone 
mice having different genes predisposing them to autoimmune disease. One model 
involves targeted disruption of candidate immune system genes to study their role 
in disease. Gene targeting experiments modify or remove a gene of interest and then 
watch for corresponding effects on the organism’s physiology. Interpretations of results 
from these experiments have traditionally 
been predicated on the assumption that 
the “background,” or nontargeted, genes do 
not contribute to observed physiological 
changes. Yet in some studies, mice without 
targeted mutations develop an unexpected 
susceptibility to the autoimmune disease under 
study.
To investigate what effects background 
genes might be having in these mouse models, 
Marina Botto and colleagues compared the 
genomes of three hybrid strains of the most 
commonly used genetic background—the 129 
and C57BL/6 hybrid mice. One of the hybrids, 
which carries a mutation in both copies of 
the Apcs gene, was chosen as an example of a 
gene-targeted model that develops a lupus-like 
disease, offering an opportunity to examine the 
relative contributions of the targeted versus 
background genes. Apcs is a candidate gene for human systemic lupus erythematosus 
(SLE), a form of autoimmunity marked by chronic inﬂ  ammation resulting from a 
sustained attack on antibodies throughout the body. 
Botto and colleagues found that several genomic regions from both the 129 and 
C57BL/6 mice contributed to autoimmunity, even in the absence of gene-targeted 
mutations. All of the hybrid strains developed autoimmunity, though disease was more 
severe in mice with Apcs mutations. Disease outcome in gene-targeted mice, it turns out, 
can be inﬂ  uenced not just by disease-susceptible (or disease-resistant) gene variants 
near the targeted gene (in this case, Apcs) but by the random heterogeneity of the 
hybrid genetic background: multiple combinations of genes in the hybrids can produce 
the same result. 
These results fall in line with mounting evidence that background genes are not silent 
partners in gene-targeted disease models, but can themselves facilitate expression 
of the disease. This ﬁ  nding underscores the notion that genes are not solitary, static 
entities; their expression often depends on context. With genetically complex diseases, 
having the requisite combination of susceptibility genes does not always lead to disease. 
Much work remains to be done to identify the triggers that cause the immune system to 
turn on itself. For more on mouse models and autoimmunity, see the primer by Morel in 
this issue.
Bygrave AE, Rose KL, Cortes-Hernandez J, Warren J, Rigby RJ, et al. (2004) Spontaneous 
autoimmunity in 129 and C57BL/6 mice—Implications for autoimmunity described in gene-
targeted mice. DOI: 10.1371/journal.pbio.0020243
Identifying Genes Involved in 
Innate Immunity through RNAi
DOI: 10.1371/journal.pbio.0020249
An organism’s ability to sense 
and respond to potentially harmful 
pathogens is key to its survival. To ﬁ  ght 
off disease and infection, organisms 
must detect pathogens, activate immune 
cell signaling pathways, and produce 
molecules able to thwart a pathogenic 
attack. So fundamental is this need 
that molecules and protein domains 
related to innate immunity are evident in 
organisms as diverse as plants, ﬂ  ies, and 
humans, highlighting the ancient origins 
of defense mechanisms. Once detected, 
the pathogen’s presence triggers a 
cascade of signaling events that generate 
a rapid response tailored to speciﬁ  c 
classes of pathogens.
When pathogens attack the Drosophila 
fruitﬂ  y, they elicit a range of defensive 
reactions in the ﬂ  y, including the 
production of antimicrobial proteins, 
phagocytes (which engulf the pathogen), 
and toxic metabolites. A microbe sets off 
one of these responses by interacting 
with a receptor, triggering a pathway that 
activates a special class of transcription 
factors, which in turn activate genes 
needed to make antimicrobial peptides, 
say, or toxins. Drosophila attacked by 
fungi and a certain class of bacteria 
activate these transcription factors 
through a pathway (the Toll pathway) 
that also operates in mammals. 
A second pathway is activated when 
a different class of bacteria attack. While 
the general steps of this pathway, called 
the Immune deﬁ  ciency (Imd) pathway, 
are known—Dredd-mediated activation 
of the Relish transcription factor, for 
example, is central to this antibacterial 
response—the details and mechanisms 
remain unclear. Signaling pathways 
are notoriously complex and the Imd 
pathway is no different. In the current 
model, bacterial pathogens stimulate a 
transmembrane receptor, which activates 
the Imd protein, which then transmits 
the signal through intermediary proteins, 
which ultimately activate Dredd, sending 
Relish into the nucleus to activate genes 
required for an immune response.  
In this issue of PLoS Biology, Edan 
Foley and Patrick O’Farrell use a 
genome-wide approach to characterize 
the Imd pathway, with an eye toward 
understanding what regulates the 
Dredd-Relish interaction. To identify 
DOI: 10.1371/journal.pbio.0020220.g001
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pertinent genes and their roles, Foley and 
O’Farrell took advantage of a technique, 
called RNA interference (RNAi), that can 
selectively target and “silence,” or inhibit, 
nearly any gene. After silencing a gene, 
researchers can then track how a cell 
responds and infer the gene’s function. 
The technique uses double-stranded 
RNA (dsRNA) molecules with nucleic 
acid sequences that match a gene of 
interest (RNA can bind to DNA through 
complementary base pairing). The 
dsRNAs precipitate a series of steps that 
ultimately degrade the messenger RNA 
associated with the gene, preventing 
messenger RNA translation, thereby 
silencing the gene. 
The authors produced over 7,000 
dsRNAs corresponding to most of the 
Drosophila genes with counterparts in 
mammals or the worm C. elegans (that 
is, conserved genes), then developed 
a cell culture model to analyze the 
components of the Imd pathway. Since 
the cells in these cultures respond to 
the presence of bacterial proteins by 
generating antimicrobial peptides, they 
provide a good testbed for identifying 
genes involved in the pathway. Foley and 
O’Farrell’s RNAi screen identiﬁ  ed many 
molecules involved in signaling, including 
both signal inhibitors and activators. 
Among these signaling components, they 
discovered two new genes: one, which 
they named sickie, is required to activate 
Relish; the second, called defense repressor 
1 (dnr1), appears to inhibit Dredd 
activity and thus inhibit the pathway. 
Based on molecular analysis of these 
genes—which involved exposing cells to 
bacterial proteins—the authors propose 
a model of Imd signaling in which Dredd 
and the protein produced by dnr1, 
called Dnr1, operate through a negative 
feedback loop: Dredd activity appears 
to promote the accumulation of its own 
inhibitor, Dnr1. Since suppression of Dnr1 
through RNAi can trigger an immune 
response, the authors explain, it appears 
that interruption of this feedback loop 
activates the signaling pathway. Without 
the inhibitory action of Dnr1, Dredd can 
activate Relish, which dissociates from 
Dredd, enters the nucleus, and activates 
the transcription of antimicrobial genes. 
It’s likely that the two genes described 
here play a key role in activating 
Relish, the authors conclude, and that 
others identiﬁ  ed in this screen will also 
prove signiﬁ  cant. Since many of these 
components are conserved in mammals, 
the pathway may likewise operate in 
humans. Future experiments will be the 
test of these assumptions, but until then, 
Foley and O’Farrell have demonstrated 
the soundness of using RNAi screens on 
a large scale to dissect the elements of a 
complex signaling pathway. 
Foley E, O’Farrell PH (2004) Functional 
dissection of an innate immune response by 
a genome-wide RNAi screen. DOI: 10.1371/
journal.pbio.0020203
10.1371/journal.pbio.0020249.g001
The NF-kB homolog Relish (green) 
accumulates in the nucleus of an S2 cell 
in contact with E. coli (green rod on cell 
surface) 
A Protein Required for Fruitﬂ  ies to Dispatch 
Wasp Parasites
DOI: 10.1371/journal.pbio.0020255
For a three-millimeter invertebrate, the Drosophila fruitﬂ  y 
has a remarkably sophisticated immune system. Granted, it 
can’t customize an immune response by grooming cells to 
“remember” and target speciﬁ  c pathogens. But it can rally the 
less specialized tools of innate immunity to ﬁ  ght disease and 
infection, and in so doing draws on several aspects of blood cell 
development (called hematopoiesis)—the foundation of the 
cellular immune response—also found in vertebrates.
In fruitﬂ  ies, as in vertebrates, hematopoiesis occurs in distinct 
stages and locations, with nascent cell populations migrating 
to establish new hematopoietic frontiers. A population of 
progenitor cells generates all the blood cell types in the 
organism. These cells arise in two distinct waves and in two 
distinct locations, with their progeny differentiating into the 
specialized tissues and organs of the hematopoietic system. In 
mammals, these organs include the liver and bone marrow, an 
ongoing source of blood cells after embryogenesis. In fruitﬂ  ies, 
the deﬁ  nitive hematopoietic organ is the lymph gland, which 
churns out three types of blood cells: plasmatocytes and crystal 
cells, which are also produced by embryonic hematopoietic 
precursors, and lamellocytes. Plasmatocytes account for up to 
95% of circulating fruitﬂ  y blood cells and act much like their 
mammalian counterpart, the macrophage, engulﬁ  ng substances 
deemed foreign and dangerous. Crystal cells account for most 
of the rest and are involved in melanization reactions, which 
trigger mechanisms involved in containing and killing invading 
microbes. Unlike plasmatocytes and crystal cells, lamellocytes 
appear en masse and only under certain conditions, such as the 
unwelcome appearance of parasitic wasp eggs. Lamellocytes 
encapsulate and neutralize the invader. 
10.1371/journal.pbio.0020255.g001
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Molecular factors involved in determining the 
fate of hematopoietic cells have been identiﬁ  ed 
for plasmatocytes and crystal cells but not for 
lamellocytes—until now. In a search for genes that 
might precipitate lamellocyte differentiation, Marie 
Meister, Alain Vincent, and colleagues homed in 
on a protein, called Collier (Col), that is expressed 
in lymph glands at the end of embryogenesis. 
Col is quite similar to a mammalian protein, 
called Early B-cell Factor (EBF), that controls 
B-cell development in mice. Both proteins are 
transcription factors, exerting control by initiating 
gene transcription.
To investigate Col’s part in lamellocyte 
development, the researchers had to get 
around the fact that mutations that render Col 
nonfunctional eventually kill the embryo. Using 
tricks of the genetics trade, Meister and colleagues 
generated ﬂ  y larvae that survive loss-of-function 
mutations in the gene that encodes Col, allowing 
them to study its role in hematopoiesis.
The mutants had normal amounts of circulating 
plasmatocytes and crystal cells, but when exposed 
to parasitic wasp eggs, could not muster the 
requisite response: lamellocyte production. 
With no lamellocytes, ﬂ  y larvae had no means of 
protection against encroaching wasp eggs, which, 
uncontested, developed into parasitic larvae. The 
ﬂ  ies with normal Col levels had no such problem, 
producing considerable numbers of lamellocytes. 
In these ﬂ  ies, Col expression was restricted to 
a lymph region called the posterior signaling 
center (PSC). Col’s inﬂ  uence on lamellocyte fate 
was strong enough that forcing Col expression 
in precursor blood cells induced lamellocyte 
differentiation even in the absence of wasp 
infestation. Based on these ﬁ  ndings, Meister and 
colleagues propose a model for Col-mediated 
lamellocyte differentiation in which wasp 
infestation activates Col-expressing cells in the 
PSC, which then instructs immature blood cells 
in the lymph gland to become lamellocytes and 
dispatch the gathering threat. 
 Col’s role in fruitﬂ  y hematopoiesis closely 
parallels that of its mammalian ortholog in white 
blood cell development, EBF. Both are required 
to generate specialized populations of cells in 
response to a particular immune threat, and both 
confer an extra line of defense when faced with 
special circumstances—key features of vertebrate 
adaptive immunity. Could it be that building 
blocks of adaptive immunity were already in 
place some 550 million years ago, when ﬂ  ies and 
vertebrates parted ways? Researchers will have to 
investigate the molecular agents of immunity in 
intervening species to ﬁ  nd out.
Crozatier M, Ubeda JM, Vincent A, Meister M 
(2004) Cellular immune response to parasitization in 
Drosophila requires the EBF orthologue Collier. DOI: 
10.1371/journal.pbio.0020196
The Molecular Biology of Wound Healing
DOI: 10.1371/journal.pbio.0020278
Anyone who’s endured their share of childhood scrapes has probably heard 
some version of the motherly admonishment, “Don’t pick that scab, you’ll 
just make it worse!” It turns out, Mom was on to something. Tissue damage 
in humans triggers a well-characterized response marked by rapid blood 
clotting and a recruitment of epidermal cells to the injury. When you remove 
a scab, you’re also removing some of the newly regenerated tissues growing 
underneath, thereby interfering with the healing process. 
Many different cell types and proteins have been linked to the repair 
process, but the complexity of the mammalian wound response has 
challenged efforts to determine their individual roles. Only the ﬁ  rst step—
the signaling cascade that promotes blood clotting—is understood at 
the molecular level. Since dissecting the wound response pathway at the 
molecular level requires an organism that lends itself to relatively easy genetic 
manipulations, Michael Galko and Mark Krasnow of Stanford University turned 
to the quintessential genetics organism, Drosophila melanogaster, to create 
a novel system for studying wound healing. After stabbing fruitﬂ  y larvae 
with a needle to create a nonfatal puncture wound, Galko and Krasnow then 
analyzed signiﬁ  cant morphological, cellular, and molecular events at various 
stages of healing.
Immediately after wounding, the larvae begin to bleed, and about 15 
minutes after wounding, the wound darkens and a “plug” of cellular debris 
forms in the wound. The plug staunches the bleeding and provides a 
protective layer. Within two hours the plug’s outer layer forms a dark, tough 
scab that presumably serves as an effective barrier to further blood loss. Two 
or three days later, the healing process is complete. 
Galko and Krasnow observed the activity of epidermal cells during 
healing by labeling their nuclei with a ﬂ  uorescent protein and staining their 
membranes. Soon after wounding, cells along the wound margin elongated 
and aligned themselves toward the wound, then fused together to form a 
large, multinucleate (multiple nuclei) epidermal cell surrounding the scab. 
Over the next six hours, these cells also spread along and through the plug, 
re-establishing a continuous epidermis. 
Since this epidermal spreading resembles that seen during a developmental 
stage of the fruitﬂ  y, where the process depends on the JNK signaling pathway, 
DOI: 10.1371/journal.pbio.0020278.g001
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the authors investigated JNK signaling 
to shed light on the genetics and 
cellular events of healing. Sure enough, 
they found that the JNK pathway was 
activated during the peak hours of 
wound healing. Inhibiting the pathway 
in ﬂ  y mutants—the classic approach in 
ﬂ  y genetics—had dramatic effects on 
the wound-healing process. The early 
stages of healing—including plug and 
scab formation—weren’t affected, but 
epidermal spreading to regenerate the 
intact epidermis was either blocked or 
defective. In contrast, larvae with defects 
in a gene required for the generation 
of crystal cells—a type of blood cell 
implicated in processes linked to scab 
formation—could not properly form 
scabs. In these scabless wounds, the JNK 
pathway was hyperactive, epidermal cells 
at the wound’s margin started to spread 
to close the wound but often failed, and 
the wound did not heal. Score one for 
Mom.
But apparently Mom wasn’t totally 
right: As Galko and Krasnow discovered, 
a scab isn’t always necessary. When 
the authors pinched larvae without 
puncturing the overlying cuticle, the 
wounds did not form scabs. However, 
they still saw many of the same processes 
at work around this “pinch” wound that 
they saw around the puncture wound, 
and the pinch wounds healed efﬁ  ciently. 
This indicates, the authors argue, that 
the scab functions primarily to provide 
stability to the wound site and help 
restore tissue integrity when both the 
epidermis and overlying cuticle are 
damaged during wounding.
While the stages of wound healing 
outlined here occur at a particular time 
and place, these results suggest that each 
stage is controlled by distinct genetic 
programs and signaling pathways 
triggered by the wound. Since many 
aspects of the ﬂ  y wound response 
resemble those in mammals, it’s likely 
that the molecular components are 
also shared. That makes identifying the 
molecular underpinnings of wound 
healing a high research priority. And 
thanks to the powerful system presented 
here, this task should be all the easier.
Galko MJ, Krasnow MA (2004) Cellular 
and genetic analysis of wound healing in 
Drosophila larvae. DOI: 10.1371/journal.
pbio.0020239 
Retrovirus Integration into the Human Genome
DOI: 10.1371/journal.pbio.0020281
When gene therapy was introduced nearly ﬁ  fteen years ago, it was widely hailed as 
a panacea. Since many diseases have a genetic component, the hope was that gene 
therapy could replace compromised genes with healthy versions to treat everything 
from inherited disorders like cystic ﬁ  brosis to cancer and HIV. That great promise was 
quashed when a teenager suffering from a rare hereditary liver disorder died after 
participating in an experimental gene therapy trial in 1999: four days after being 
injected with millions of viruses engineered to deliver healthy genes to his liver, Jesse 
Gelsinger died. It seems the virus, derived from an adenovirus, targeted his immune 
cells rather than his liver cells, which triggered an immune response against the virus, 
resulting in massive organ failure.
In another case, two young boys who received gene therapy for the severe 
immunodeﬁ  ciency disorder known as “bubble boy disease” developed leukemia-like 
symptoms 30 months after treatment. In this case, the viral vector inserted itself near a 
promoter region—a site that initiates gene transcription—of a proto-oncogene, a gene 
that can initiate cancer. Since viral vectors can integrate at various genomic locations, 
the safety and effectiveness of gene therapy ultimately depends on being able to 
predict a virus’s particular bias. Comparing retroviral vectors derived from three viruses, 
including two common gene therapy vectors, Rick Mitchell et al. report 3,127 sites where 
these viruses typically integrate into the human genome. The different vectors, they 
found, show different target preferences.
Retroviruses use viral enzymes to copy their own genome, which is stored in an RNA 
transcript, into DNA. Now recognizable by the host’s genome, the virus can integrate 
into one of the host’s chromosomes. In this study, Mitchell et al. studied vectors derived 
from the human immunodeﬁ  ciency virus (HIV), avian sarcoma-leukosis virus (ASLV), and 
murine leukemia virus (MLV). Introducing the viral vectors into human cells, the authors 
analyzed the gene expression proﬁ  les of the cells to determine where vectors integrate 
into human chromosomes and which, if any, genes they activate. Mitchell et al. then 
compared the integration sites with the transcription proﬁ  les.
Each retrovirus, they discovered, showed distinct preferences for genome integration. 
HIV vectors tend to integrate into sites of active transcription, favoring chromosomal 
regions rich in expressed genes. MLV vectors tend to integrate near transcription 
initiation sites, conﬁ  rming the results of a previous study, with a weak bias toward active 
genes. In contrast, the authors report, the ASLV vector “does not favor integration near 
transcription sites, nor does it strongly favor active genes.”
Early efforts to understand how chromosomes may inﬂ  uence where viruses insinuate 
themselves into a chromosome focused on factors governing accessibility. Viruses are 
more likely to be integrated into chromosomal regions that are more accessible, which 
tend to be transcriptionally active sites. But since each of the three viruses studied here 
routinely targeted different sequences, the authors note, accessibility is probably just 
one factor. Speciﬁ  c chromosomal proteins, for example, might interact with the viral 
integration machinery and facilitate integration at nearby sites. Another possibility, the 
authors propose, is that DNA-binding proteins that bind to speciﬁ  c DNA sequences 
assist integration of one virus while impeding another.
This could explain why ASLV behaved as it did in the human cells studied here. The 
virus might have more reﬁ  ned integration preferences during normal infection of 
chicken cells, the authors note, but its integration machinery can’t interact properly with 
human cells. The leukemia-like effects of the bubble boy gene therapy stemmed from 
integration of a mammalian retrovirus—the MLV vector—near an oncogene promoter 
region. Since ASLV tends to avoid both transcription initiation sites and active gene sites, 
it could be a more promising candidate for human gene therapy. With the draft chicken 
genome sequence now complete, researchers can investigate whether that proves 
true. But for now, Mitchell et al. make the case that scientists can gain more control over 
where viral vectors integrate into the human genome by selecting different retroviral 
integration systems. Only time will tell whether more control translates into safer gene 
therapy protocols.
Mitchell RS, Beitzel BF, Schroder SRW, Shinn P, Chen H, et al. (2004) Retroviral DNA 
integration: ASLV, HIV, and MLV show distinct target site preferences. DOI: 10.1371/journal.
pbio.0020234PLoS Biology  |  www.plosbiology.org 1046 August 2004  |  Volume 2  |  Issue 8  |  e284  |  e270
Deterministic Tumor Evolution
DOI: 10.1371/journal.pbio.0020284
The essential difference between 
cancer cells and normal cells is that 
cancer cells evolve. Most cancers arise 
from a single cell through a sequential 
evolutionary process of mutation and 
selection. Cancer cells harbor mutations 
in a number of critical genes that, at 
various stages during the evolution of the 
tumor, provide those cells with a selective 
advantage. Many of the phenotypes, 
or physical outcomes, conferred by 
these mutant genes are subverted from 
a normal cell’s repertoire, including 
proliferation, invasion, migration, loss 
of differentiation, and loss of apoptosis 
(programmed cell death); other 
phenotypes, such as immortalization, 
are novel. Tumor evolution is thought 
to adhere to Darwinian principles, with 
mutations arising randomly within an 
individual cell, followed by selection for 
mutant clones with favorable traits. 
Support for this idea stems from the 
observation that end-stage tumors have 
mutations in a number of genes. But 
linking mutations in particular genes with 
deﬁ  ned stages is difﬁ  cult for most human 
cancers and especially so for the last and 
deadliest stage: when cancer disseminates 
throughout the body during metastasis. 
It’s unclear, for example, whether there 
are mutations in particular genes or sets 
of genes that enhance metastasis. That 
is, do metastatic lesions develop through 
a continuation of Darwinian evolution, 
or is metastasis an intrinsic property of 
the primary tumor, meaning that further 
genetic evolution is not required? It is 
also unclear whether there is a “preferred” 
sequence of mutations, such that selective 
pressure for particular mutations depends 
on preexisting mutations. 
Since the earliest days of research on 
oncogenes—genes that can cause a 
cell to become cancerous—it has been 
known that certain oncogenic mutations 
cooperate to transform normal cells into 
cancer cells. For example, an “activating” 
mutation in the oncogene Ras and 
the loss of the tumor suppressor p53 
cooperate to transform cells. 
The paper by Christopher Kemp and 
his colleagues at the Fred Hutchinson 
Cancer Research Center sheds light on 
some of these questions, and many of the 
issues center around the most notorious 
oncogene: Ras. Using a well characterized 
mouse model of squamous cell 
carcinogenesis, which generates a form of 
skin cancer, the authors examine both the 
functional and evolutionary relationships 
between three cancer genes that play 
major roles in most human cancers: Ras 
and the tumor suppressors Arf and p53. 
Two seminal early observations set 
the stage: mutational activation of Ras is 
the initiating genetic event in this cancer 
model, while mutation of p53 occurs 
later, during the benign to malignant 
transition; and expression of mutant 
Ras in cells activates p53 via signaling 
through the protein encoded by Arf. 
Kemp et al. conﬁ  rm that this pathway 
is active in “autochthonous” tumors—
which grow and develop where they 
are initiated—by showing that p53 
expression in tumors with Ras mutations 
is dependent on the presence of Arf. 
Thus, during the early benign stages of 
tumor growth, Ras activates Arf, which 
in turn activates p53, 
thereby inhibiting tumor 
progression. This provides 
strong selective pressure 
in favor of cells with 
mutations in either Arf or 
p53, and these mutations 
are indeed observed as 
the tumors progress to 
malignancy. That Arf and 
p53 function as tumor 
suppressors was conﬁ  rmed 
by demonstrated 
accelerated tumor 
progression in mice lacking 
either Arf or p53. This 
answers a longstanding 
question concerning 
the nature of the signal 
that activates p53 during 
autochthonous tumor development: 
Mutation of Ras not only initiates tumor 
development but, through its intracellular 
signaling through Arf and p53, directly 
inﬂ  uences the subsequent evolutionary 
trajectory of the tumors. In this view, 
secondary evolutionary events are 
determined by the preexisting genetic 
lesion, as a result of direct signaling 
interactions. 
The authors go on to show that tumors 
lacking Arf or p53 show accelerated 
metastatic dissemination, a phenomenon 
rarely seen in mouse squamous cell 
cancer models. Thus both benign and 
malignant tumors lacking these tumor 
suppressors are at high risk for metastasis. 
As Ras is well known to confer many 
phenotypes required for the metastatic 
process, it appears that Ras, together 
with loss of its inhibitors, Arf and p53, 
may be sufﬁ  cient to drive this process. 
More direct evidence that metastasis 
does or does not require further genetic 
evolution awaits. 
Kelly-Spratt KS, Gurley KE, Yasui Y, 
Kemp CJ (2004) p19Arf suppresses growth, 
progression, and metastasis of Hras-driven 
carcinomas through p53-dependent and 
-independent pathways. DOI: 10.1371/
journal.pbio.0020242
Inhibition of the DNA Damage 
Pathway by a Telomere-
Binding Protein
DOI: 10.1371/journal.pbio.0020270
To maintain the integrity of their 
genetic content, cells closely monitor 
the state of their chromosomal DNA. 
Any break or pairing anomaly in the 
double helix is perceived as damage 
that must be repaired. Mechanisms that 
sense DNA damage enlist the help of cell 
cycle checkpoint proteins, which stall 
cell division until the damage has been 
repaired. The exposed ends of linear 
chromosomes of eukaryotic cells (cells 
with nuclei) resemble the double-strand 
breaks of damaged DNA, which should 
make them vulnerable to unnecessary 
manipulations by repair enzymes. 
But chromosomes have special DNA 
sequences at their tips, called telomeres, 
that are coated with telomere-binding 
proteins that appear to protect ends 
from the unwanted attentions of repair 
enzymes. For instance, removing a 
telomere-speciﬁ  c DNA-binding protein, 
called TRF2, from telomeres leads to 
a rapid attack on chromosome tips, 
DOI: 10.1371/journal.pbio.0020284.g001
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associated with the activation of the DNA damage 
pathway. The biochemical basis for TRF2’s shielding 
effects remains obscure.
In this issue of PLoS Biology, Jan Karlseder et al. 
propose that TRF2 is a direct inhibitor of an early 
mediator of the DNA damage signal. Their observations 
offer new insights into how telomeres resist the 
inappropriate interventions of the DNA repair 
machinery.
Ataxia telangiectasia mutated (ATM) kinase is an 
enzyme that induces the activation of DNA repair 
enzymes as well as regulators of the cell cycle and 
apoptosis. Its enzymatic function is triggered by DNA 
damage sensors. Several observations suggest an 
antagonism between TRF2 and ATM: ATM is activated in 
aging cells with shortened telomeres and participates 
in ushering the cell into replicative senescence. (Cells 
divide only so many times during their lives before 
forgoing the process altogether.) In contrast, TRF2 
overexpression protects shortened telomeres from 
decay and delays cell entry into senescence. 
Here the authors examine the effect of TRF2 
overexpression in cells subjected to radiation-induced 
DNA damage. This treatment is expected to lead to cell 
cycle arrest, an outcome mediated for the most part 
by ATM activation. Irradiated cells that overexpress 
TRF2, however, continue to enter cell division. Known 
targets of ATM’s enzymatic activity are activated to a 
lesser degree in these cells, which harbor only about 
half the amount of active ATM detected in controls. This 
suggests that TRF2 may interfere with the DNA damage 
pathway early on, when ATM is activated.
Do these ﬁ  ndings reﬂ  ect a direct interaction 
between ATM and TRF2? Karlseder et al. suggest they 
might. Though only a small fraction of TRF2 associates 
with ATM in normal cells, ATM and TRF2 proteins can 
form a complex in a test tube. The region of the ATM 
protein that interacts with TRF2 is the very region 
required for ATM’s activation by DNA damage sensors. 
The authors propose that TRF2 binds to inactive ATM, 
and in so doing, prevents ATM’s transition to an active 
state. 
The authors integrate their results in an elegant 
proposal that relates a cell’s health to the length of its 
telomeres. They have previously shown that TRF2 binds 
another protein called Mre11, a DNA damage sensor 
known to activate ATM. Thus, by inhibiting ATM, TRF2 
may nip in the bud any misguided attempts by Mre11 
to “repair” DNA breaks in telomeres. But in aging cells, 
whose shortened telomeres no longer retain large 
amounts of TRF2, ATM activation, no longer mufﬂ  ed, 
eventually allows the onset of senescence. While TRF2 
is abundant in normal cells, the authors note that its 
strict association with telomeres should locally limit its 
effect on ATM, leaving the DNA damage pathway intact 
at other chromosomal locations. 
Karlseder J, Hoke K, Mirzoeva OK, Bakkenist C, Kastan 
MB, et al. (2004) The telomeric protein TRF2 binds the 
ATM kinase and can inhibit the ATM-dependent DNA 
damage response. DOI: 10.1371/journal.pbio.0020240
Evolution’s “Molecular Clock”: 
Not So Dependable After All?
DOI: 10.1371/journal.pbio.0020287
DNA mutates, and it’s a good thing it does. If it didn’t, there could only 
be one kind of life, not the millions there are today, and species could not 
adapt to new challenges. This is because mutations in genes—the coding 
portion of DNA—are the raw material for evolution. However, genes make 
up a surprisingly small fraction of our DNA. If the genome were a cookbook, 
its 30,000-odd genetic recipes would be scattered among millions of pages 
of apparently meaningless nonsense.
Mutations affect all DNA, not just the genes, and this provides 
population geneticists with a veritable toolbox of methods useful, for 
example, in DNA proﬁ  ling. Importantly, all these methods rely on the idea 
of a “molecular clock,” the notion that mutations rain down on noncoding 
DNA like a ﬁ  ne drizzle, so constantly that genetic similarity is a good 
measure of evolutionary time. Thus, if orangutans diverged from humans 
twice as long ago as did chimpanzees, on any given piece of DNA we would 
ﬁ  nd twice as many differences between the orangutan sequence and the 
human sequence as between 
humans and chimps. The 
mutations are marking time.
If the molecular clock 
works, scientists can do 
wonderful things like 
estimating how long ago 
it was that the common 
ancestor of all humans 
lived, or when birds evolved 
from dinosaurs. The clock 
assumes that mutations 
occur independently of each 
other and at a constant rate. 
By analyzing thousands of 
noncoding DNA sequences 
scattered throughout the 
human genome, Edward 
Vowles and William Amos 
have found that the clock 
is anything but constant. Instead, a mutation in one spot in the genome 
affects the chance of getting another mutation nearby. 
Not all noncoding DNA is made up of benign tracts of random letters. 
Some sequences appear to be more difﬁ  cult to copy than others, and these 
trouble spots can give rise to alphabetic stuttering. DNA is made up of four 
component chemical units, called nucleotides, which are often referred to 
by their initial letters: A, C, G, and T. Stuttering occurs when the same pairs 
or triplets of letters occur together, for example ACACAC. Such regions are 
called microsatellites, and instead of mutating by swapping one letter for 
another, as most nucleotides do, these sequences evolve mainly by gaining 
and losing triplets or pairs like “AC.” 
In this study, Vowles and Amos used the published sequence of the 
human genome to track down and compare thousands upon thousands 
of microsatellites. If the molecular clock ran smoothly, they would expect 
to ﬁ  nd no similarity at all between the DNA sequences surrounding any 
pair of unrelated microsatellites. To their surprise, they found the complete 
reverse, with entirely unrelated microsatellites showing widespread and 
obvious similarities in their ﬂ  anking DNA. This meant that mutations near 
microsatellites were not random, but favored certain letters in certain 
positions. Just as a new shipwreck will attract its own special community of 
marine life, so microsatellites appear gradually to change the surrounding 
DOI: 10.1371/journal.pbio.0020287.g001
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DNA towards a common pattern. The result is convergent evolution, an unusual state of 
affairs where, as time goes by, DNA sequences become more similar, not less.
As yet, the exact mechanisms remain unclear, though it probably has something to do 
with how comfortably different combinations of letters sit next to each other. In English, 
“U” always follows “Q” and “B” never follows “V.” Similar rules may apply to DNA, albeit on 
a much subtler level. For example, if a microsatellite contains alternating As and Cs, the 
ﬂ  anking regions also tend to have As at alternate positions, in phase with the As in the 
microsatellite. It is as if the DNA prefers the pattern in the microsatellite to extend into 
the ﬂ  anking DNA, rather than abruptly stopping at the end of the microsatellite. 
These ﬁ  ndings suggest that it may be wise to take the notion of a molecular clock 
at face value. With a perfect clock, two or three identical mutations would be highly 
unlikely, but we now know that this may be possible near microsatellites. Vowles and 
Amos estimate that as much as 30% of the genome may show evidence of convergent 
evolution, simply because microsatellites are so common. These mutation biases 
probably exist to a lesser extent in most sequences. Once scientists understand more 
fully how and where these biases operate, they may be able to estimate more accurately 
the risk of any given mutation occurring, be it one that causes human disease or makes 
a virus more virulent. These ﬁ  ndings represent yet another windfall from the Human 
Genome Project, and act as a powerful reminder that unexpected results always lurk 
around the corner as we delve deeper into the secret world of the genome. 
Vowles EJ, Amos W (2004) Evidence for widespread convergent evolution around human 
microsatellites. DOI: 10.1371/journal.pbio.0020199 
Regenerating Lost Muscle: 
Msx1 to the Rescue
DOI: 10.1371/journal.pbio.0020266
Cell and molecular biologists have 
a good start at understanding the 
adult salamander’s enviable ability to 
completely regrow a lost limb or jaw. 
(Salamanders can even regenerate 
portions of their eyes and heart.) 
Happily, mammals share many of the 
required cellular skills—though in an 
untapped form. In response to injury, fully 
differentiated salamander muscle cells 
can produce less specialized cells that 
are capable of multiplying and recreating 
lost tissue. In this month’s PLoS Biology, 
biochemist Jeremy Brockes and his 
colleagues at University College London 
tie this muscle cell de-differentiation to 
expression of a single gene, Msx1, a player 
in limb development and regeneration 
across species.
The protein encoded by Msx1 appears 
at the borders of maturing tissues in 
salamanders, chickens, and mice, and 
represses differentiation of muscle cells 
(called myoﬁ  bers) during development. 
Msx1 promotes amphibian limb and tail 
regeneration, zebraﬁ  sh ﬁ  n repair, and 
regrowth of the tips of digits in 
mice. Here, Anoop Kumar et al. 
clarify the gene’s role in muscle 
repair by demonstrating that 
Msx1 expression is required 
for de-differentiation of 
salamander myoﬁ  bers—
mature muscle tissue without 
the ability to produce new 
cells—into cells with single 
nuclei (mononucleate cells) 
that are able to multiply.
Large, elongated cells, 
myoﬁ  bers are distinguished 
by a striped pattern of actin 
and myosin, the proteins that 
produce muscle contractions. 
They develop from precursor 
cells, which proliferate and 
fuse together into multinucleate 
intermediates called myotubes. As 
myotubes bulk up on actin and myosin, 
pushing their many nuclei to the cell 
periphery, they mature into myoﬁ  bers. 
Once differentiated, myoﬁ  bers are 
committed to the life of a muscle 
workhorse. They cannot divide; mature 
muscle in mammals adds strength and 
repairs injury by accumulating more actin 
and myosin, and by fusing single-nucleus 
“satellite” cells into new or existing 
myoﬁ  bers. 
Unlike their mammalian counterparts, 
salamander and newt myoﬁ  bers respond 
to injury by splitting into several 
multinucleated fragments, or by budding 
off several of their nuclei to create 
individual cells. These mononucleate 
progeny multiply and develop to replace 
lost tissue. Kumar et al. found that more 
than half of salamander myoﬁ  bers 
spontaneously fragment and bud when 
dissected and placed in cell culture. Prior 
study has shown that mouse myoﬁ  bers 
don’t normally behave this way, although 
cultured mouse myotubes can imitate 
amphibian myoﬁ  bers if given a push, in 
the form of Msx1. A fraction of mouse 
myotubes made to express Msx1 break 
off mononucleate cells that can be 
induced to express markers for bone, 
cartilage, fat, or muscle. 
In the salamander cells, Msx1 RNA and 
protein appeared in actively fragmenting 
and budding myoﬁ  bers, especially in and 
around their nuclei. When Kumar et al. 
blocked the translation of Msx1 mRNA, 
the myoﬁ  bers did not generate new cells.
The results conﬁ  rm Msx1 as a pivotal 
regulator of muscle cell re-entry into the 
cycle of cell division and tissue growth. 
In this context, it doesn’t drive cell 
division—on the contrary, the authors 
showed that Msx1 induced cell splitting 
without DNA replication. The gene drove 
committed muscle cells to donate nuclei, 
creating a pool of new cells to divide, 
differentiate, and repair damage. Given 
what it can do for mouse cells in culture, 
the question remains whether Msx1 
might help awaken a latent capacity for 
regeneration in living mammals.
Kumar A, Velloso CP, Imokawa Y, Brockes 
JP (2004) The regenerative plasticity 
of isolated urodele myoﬁ  bers and its 
dependence on Msx1. DOI: 10.1371/
journal.pbio.0020218
10.1371/journal.pbio.0020266.g001
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Finding Mutations That Disrupt 
Cortical Development 
DOI: 10.1371/journal.pbio.0020254
As the presumed “seat of 
consciousness,” the cerebral cortex 
mediates the higher-level cognitive 
processing—such as abstract 
thought—that humans like to think 
distinguishes them from other animals. 
The cerebral cortex is, in fact, signiﬁ  cantly 
larger in the human brain and has far 
more “columns” than it does in other 
mammals, particularly compared to the 
rat, a traditional model for brain study. 
Neurons in these cortical columns have 
similar response properties and form 
fundamental units of brain processing. 
It is the larger brain surface area, 
accommodating a greater number of 
cortical columns, that gives humans the 
computational edge. 
By studying the genetic and molecular 
agents of cortex development, scientists 
hope to understand the nature and 
extent of cortical cognitive function 
and identify effective therapies to repair 
brain injury and disease. Analyses of 
mutant mice have provided insights into 
the mechanisms controlling cerebral 
cortex development, but many details 
of cortical development remain to be 
revealed. Identifying individual molecules 
and genes involved in discrete brain 
processes is particularly difﬁ  cult given 
the complexity of brain structure and 
function. Geneticists have traditionally 
linked genes to speciﬁ  c biological 
pathways by ﬁ  rst screening large 
numbers of individuals of a species for 
unusual physical traits (phenotypes) and 
then determining the genetic makeup of 
these mutants to home in on the faulty 
gene. This approach, called forward 
genetics, typically requires large numbers 
of individuals to ﬁ  nd unusual phenotypes 
and so has traditionally focused on fast-
breeding organisms like zebraﬁ  sh and 
fruitﬂ  ies. But zebraﬁ  sh and fruitﬂ  ies are 
unlikely to reveal the secrets of higher 
consciousness. 
Now Andrew Peterson and colleagues 
have updated the forward genetic 
screen and added a new resource to 
the neuroscientist’s “brain dissection” 
toolkit. Their approach, which labels 
speciﬁ  c populations of neurons with 
protein “reporters,” offers a novel way to 
ﬁ  nd mutations in developing neurons 
and to identify mutations that interfere 
with cerebral cortex development. The 
reporter used here highlights mutations 
that disrupt interneuron migration 
into the cortex as well as those that 
affect cortex growth and morphology. 
(Interneurons are one of the primary 
types of cortical neurons.)
Like most forward genetic approaches, 
the researchers started with a genetically 
well-characterized breed, then used 
a chemical mutagen to damage the 
organism’s DNA. After two or three 
rounds of breeding, the researchers 
looked for cortical-related defects in 
the developing embryos. In this case, 
however, the region of the mouse brain 
that gives rise to developing interneurons 
was labeled in the original mice. Thus, 
when the researchers screened for 
mutants with defects associated with 
forebrain development and interneuron 
migration, they could easily ﬁ  nd the cells 
and genes involved. 
The screen identiﬁ  ed thirteen 
mutations affecting cortical development 
and interneuron migration. (Developing 
neurons travel along the ﬁ  bers of other 
brain cells before reaching their ultimate 
destination in the brain.) Three mutations 
are variants of genes known to play a role 
in cortical development; nine mutations 
were in genes that had not been linked to 
cortical development before. 
The screen described here takes 
advantage of a chemical mutagen (called 
ENU) that induces mutations at a single 
base pair, or nucleotide, in DNA. These 
mutations tend to have quite selective 
effects on protein function—by changing 
the composition of a single domain—
which can provide information on how 
the protein should normally function and 
highlight its role in a particular process. 
The selective nature of ENU, the authors 
argue, offers new information about 
how the mutated genes identiﬁ  ed here 
function in cortical development and 
how these putative roles might be tested. 
Altogether, the results suggest that 
this type of focused screening, so long 
a resource in ﬂ  y genetics, can be a 
powerful tool in mammalian biology 
as well. That the strategy outlined here 
could identify novel mutations in a 
process as complicated as cerebral cortex 
development suggests that it could do 
the same for a broad range of biological 
processes. If the success of other model 
systems moving in this direction is any 
indication, this new strategy in the mouse 
offers researchers a powerful resource for 
identifying the genetic underpinnings of 
living systems.
Zarbalis K, May SR, Shen Y, Ekker M, 
Rubenstein JL, et al. (2004) A focused 
and efﬁ  cient genetic screening strategy 
in the mouse: Identiﬁ  cation of mutations 
that disrupt cortical development. DOI: 
10.1371/journal.pbio.0020219
10.1371/journal.pbio.0020254.g001
Distribution of GABAergic interneurons in 
wild-type (top) and mutant (bottom) cortex
A Red-Blooded Transcription Factor
DOI: 10.1371/journal.pbio.0020282
Every multicellular organism depends on the coordinated actions of a multitude of 
cell types, each designed to carry out speciﬁ  c jobs. In vertebrates, for example, the task 
of ferrying oxygen to organs, tissues, and cells throughout the body is shouldered by red 
blood cells. These cells must develop early in the embryo to nourish the body and must 
be maintained at the right levels throughout adulthood to keep the organism healthy. 
Specialized red blood cells arise from undifferentiated stem cells in a developmental 
process called hematopoiesis. All vertebrates have the same basic plan for 
hematopoiesis during their development, with one group of stem cells producing 
embryonic blood cells and, later, another group in a different part of the body making 
adult blood cells. Such developmental programs are tightly orchestrated by suites of 
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But which transcription factors act—and how and where they act—is still largely 
unknown. Scientists and doctors alike want to better understand differentiation in order 
to grasp not only how it proceeds normally but also how it can go wrong and lead to 
diseases, such as leukemia, in which white blood cells become cancerous, and aplastic 
anemia, in which bone marrow stem cells make too few red blood cells.
To discover the genes involved in hematopoiesis, Leonard Zon’s group at Children’s 
Hospital, Boston, and their collaborators exposed zebraﬁ  sh to mutagens and then 
studied the individuals that developed relevant disorders. In 1996, the group produced 
three zebraﬁ  sh lines with embryos lacking fully differentiated red blood cells; since these 
ﬁ  sh also had especially shimmery tails, the lines were named moonshine.
Now Zon and 
his colleagues 
have identiﬁ  ed 
the mutant gene 
responsible for 
the moonshine 
zebraﬁ  sh lines’ 
peculiar traits. The 
moonshine (mon) 
gene, it turns 
out, encodes a 
transcription factor 
with wide effects 
on the embryo’s 
mesoderm, the 
set of cells that 
eventually form 
the circulatory 
system, muscles, 
and skeleton. The 
researchers found 
that all three lines 
of mutant zebraﬁ  sh 
had mutations in 
the mon gene. 
In the mutant 
ﬁ  sh, stem cells 
that produce red 
blood cells were 
present initially, 
but the defective 
moonshine protein 
was unable to keep the blood cells alive. These blood cells underwent apoptosis, or 
programmed cell death, leaving the ﬁ  sh unable to make red blood cells, and they died at 
about two weeks old.
The researchers found that the protein encoded by the mon gene is most similar to 
the human and mouse Tif1-gamma, one of a family of proteins known to link DNA-
binding proteins with other factors that activate or repress gene activity. Using a DNA 
analysis technique in mouse cell cultures, the researchers found Tif1-gamma in nuclear 
bodies, multi-protein complexes in cell nuclei that help regulate gene expression. But 
the Tif1-gamma nuclear bodies didn’t ﬁ  t into any known class of such complexes, so 
it’s an open question how Tif1-gamma acts and what other proteins help regulate it. 
Finding a transcription factor such as Tif1-gamma involved in early cell specialization 
opens a door to a suite of studies on the targets of the transcription factor, as well as 
other genes that act along with mon to affect red blood cell development.
Ransom DG, Bahary N, Niss K, Traver D, Burns C, et al. (2004) The zebraﬁ  sh moonshine gene 
encodes transcriptional intermediary factor 1γ, an essential regulator of hematopoiesis. DOI: 
10.1371/journal.pbio.0020237
DOI: 10.1371/journal.pbio.0020282.g001
Hemoglobin staining shows that hematopoiesis is defective in a 
moonshine mutant (bottom) compared to a wild-type zebraﬁ  sh 
embryo (top).
Yeast Use Dual Gain Controls to 
Amplify Protein Processing
DOI: 10.1371/journal.pbio.0020269
Machinery within the endoplasmic 
reticulum (ER) of eukaryotic cells 
modiﬁ  es, folds, and assembles proteins as 
needed to suit their functions at or past 
the cell membrane. When this system 
is hampered or overtaxed, a buildup of 
unfolded or misfolded proteins within 
the ER triggers the “unfolded protein 
response,” which alerts the nucleus to 
boost production of protein-processing 
machinery that helps proteins fold. This 
system for adjusting manufacturing 
capacity is similar in organisms from 
yeast to human. If the unfolded protein 
response cannot be turned on when 
needed, cells die. Prior study suggested 
that, in yeast cells, the response to 
unfolded protein buildup is binary: 
either off or on. In this month’s PLoS 
Biology, biochemist Peter Walter and 
his colleagues from the University of 
California at San Francisco demonstrate 
two new signaling mechanisms that 
appear to give the yeast unfolded protein 
response the means for amplitude 
adjustment.
In yeast, a transcription regulator 
called Hac1p activates the genes 
required for the unfolded protein 
response. A cytoplasmic pool of HAC1 
messenger RNA waits in readiness for 
ER emergencies, each molecule locked 
against translation into protein by 
intronic RNA sequences that interrupt 
mRNA translation. Accumulation of 
unfolded or misfolded proteins in the 
ER releases this translational block, 
triggering production of Hac1p and 
activating the unfolded protein response. 
Previously, this binary HAC1 signal 
DOI: 10.1371/journal.pbio.0020269.g001
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was the only known regulator of the 
unfolded protein response in yeast. In 
two complementary papers, Walter and 
colleagues now present evidence that 
the repertoire includes new factors and 
regulators that amplify the unfolded 
protein response under conditions of ER 
stress. 
Leber et al. stressed yeast cells by 
exposing them to substances that cause 
protein misfolding or buildup in the 
ER. In response, the cells ratcheted up 
transcription levels of HAC1 several-
fold. Primed with high levels of HAC1 
mRNA, the cells were ready to produce a 
bumper crop of Hac1p and to induce a 
supercharged unfolded protein response. 
In the accompanying paper by Patil et 
al., the authors show that Hac1p is not 
working alone. A second regulator of 
transcription called Gcn4p is required 
to activate most of the genes associated 
with the unfolded protein response. 
The regulatory elements of these genes 
now appear far more diverse than 
previously appreciated. The authors 
propose that cells adjust the levels of 
Hac1p and Gcn4p to drive a continuum 
of transcriptional programs equipped to 
deal with incoming challenges. Together, 
these two papers demonstrate that the 
control of the unfolded protein response 
is far from a simple on/off mechanism, 
but exhibits complex ﬁ  ne-tuning through 
a network of signaling pathways that 
interpret and respond to the cell’s needs.
Patil C, Li H, Walter P (2004) Gcn4p 
and novel upstream activating sequences 
regulate targets of the unfolded protein 
response. DOI: 10.1371/journal.
pbio.0020246
Leber JH, Bernales S, Walter P (2004) IRE1-
independent gain control of the unfolded 
protein response. DOI: 10.1371/journal.
pbio.0020235
DOI: 10.1371/journal.pbio.0020269.g002
Control elements of UPR target genes
A New Role for a Synaptotagmin 
Protein in Calcium-Dependent 
Exocytosis
DOI: 10.1371/journal.pbio.0020253
The hardest working molecules in cell 
biology, proteins abound in a dazzling 
variety of shapes and sizes to carry out 
an equally impressive array of tasks. Many 
proteins function within the cell, while 
others get shipped out to locations both 
near and far. Specialized organelles within 
the cell package the traveling proteins 
into cargo containers called vesicles. 
Vesicles move through a highly regulated 
transportation system until they reach 
their ultimate destination, either inside or outside the cell, and release their cargo. When 
vesicles fuse to the plasma membrane and release their cargo outside the cell the 
process is called exocytosis. Exocytosis allows macromolecules to leave the cell without 
compromising the structural integrity of its membrane. 
“Professional” secretory cells specialize in producing copious quantities of their 
protein product and sending vesicles packed with their customized issue to the plasma 
membrane. Once there, the vesicles wait for a signal to fuse with the membrane. The signal 
most often comes in the form of a transient and localized increase in calcium ion levels.
Over a decade ago, researchers discovered that calcium-triggered exocytosis also 
occurs in “nonprofessional” secretory cells. In these cells, the process was thought to be 
important for healing ruptured plasma membrane, though the identity of the vesicles 
responsible remained unknown. It has been suggested that these vesicles are lysosomes, 
enzyme-ﬁ  lled organelles that break down waste and extracellular debris ingested 
by the cells. Sanford Simon, with his colleagues Jyoti Jaiswal and Norma Andrews, 
previously conﬁ  rmed that calcium does speciﬁ  cally trigger exocytosis of lysosomes in 
the “nonprofessional” secretory cells. Calcium-triggered exocytosis is thought to require 
the services of a family of proteins called synaptotagmins. But the ﬁ  fteen members of 
the synaptotagmin family diverge from this job description in various ways, calling its 
role into question. 
Synaptotagmin VII (Syt VII)—the synaptotagmin member expressed on the 
lysosomes—is present in most tissues in organisms ranging from worms to humans. 
This protein functions in processes requiring lysosomal exocytosis and during invasion 
by trypanosome parasites, such as the one that causes Chagas disease. In this issue of 
PLoS Biology, Jaiswal, Simon, and colleagues investigate the molecular mechanisms 
underlying calcium-triggered lysosomal exocytosis, focusing on the role of Syt VII. 
The researchers took cells from two lines of mice: one lacked the functional Syt VII 
protein and the other produced normal levels of Syt VII. First they labeled the surface 
and interior cavity of lysosomes in these cells with ﬂ  uorescent tags and triggered an 
increase in cells’ calcium level; then they watched the behavior of single lysosomes 
releasing their contents in real time. 
Most of the lysosomes from normal cells released only a portion of their contents and 
had very small fusion pores that remained open to the outside of the cell for only a short 
time. Interestingly, while proteins in secretory vesicle membranes typically diffuse into 
the plasma membrane during exocytosis, proteins in the lysosomal membrane stayed 
near the site of fusion. 
In the cells from Syt VII–deﬁ  cient mice, Simon and colleagues discovered, to their 
surprise, that this protein isn’t necessary for calcium-triggering of lysosomal exocytosis. 
Calcium-triggered exocytosis not only occurred in these cells, it happened more 
rapidly than in normal cells. Plus most of these deﬁ  cient lysosomes fused completely 
and their membrane proteins fully diffused into the plasma membrane. Simon and 
colleagues argue that these results show that Syt VII restricts rather than facilitates 
lysosomal exocytosis. It does so by limiting the formation and size of fusion pores and by 
preventing lysosomal membrane proteins from integrating into the plasma membrane. 
Jaiswal JK, Chakrabarti S, Andrews NW, Simon SM (2004) Synaptotagmin VII restricts fusion 
pore expansion during lysosomal exocytosis. DOI: 10.1371/journal.pbio.0020233
10.1371/journal.pbio.0020253.g001
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How the Brain Retrieves Forgotten Memories
DOI: 10.1371/journal.pbio.0020283
In the 2002 thriller Memento, the protagonist, Lenny, is plagued 
by a crippling neurological disorder that renders him incapable 
of storing memories for longer than ﬁ  fteen minutes. He wants 
nothing more than to avenge the murder of his wife, but as 
another character in the ﬁ  lm tells him, “Even if you get revenge, 
you’re not going to remember it. You’re not even going to know 
it happened.” Lenny has anterograde amnesia, a condition 
typically caused by stroke or other illness. (In the ﬁ  lm, it’s caused 
by a blow to the head.) Most forms of amnesia—including the 
more common retrograde amnesia, which involves the loss of 
long-term memory—are caused by some type of brain injury—
particularly to the hippocampus. 
Retrograde amnesia can arise from brain damage that 
interferes with memory storage, retrieval, or consolidation. 
And it is by studying retrograde amnesia that scientists have 
developed theories explaining where the brain stores memory 
traces and how it consolidates them into long-term memories. 
What ultimately causes amnesia—a failure to store memories or 
a failure to retrieve them—is not clear. 
A major challenge in resolving this question experimentally is 
being able to determine whether an animal has truly recovered 
a lost memory or has simply re-learned the task at hand. By 
reﬁ  ning a classic behavioral neuroscience experiment to test 
spatial learning and memory, Livia de Hoz, Stephen Martin, 
and Richard Morris have developed a novel protocol that 
distinguishes retrieval from new learning. The experiment, 
developed by Morris over ﬁ  fteen years ago, takes advantage of 
the fact that rats are good swimmers but prefer life out of water. 
Rats are placed in a pool and trained to remember the location 
of an escape platform, hidden just under the surface. (The rats 
can’t see it because the water is cloudy.)
Here, de Hoz et al. trained rats to a particular platform 
location—their escape route—then gave them hippocampal 
lesions. One group received “sham” lesions, another partial 
lesions, and a third complete lesions. Partial lesions, the authors 
explain, should damage only a subset of the stored memory 
traces and thus weaken the rats’ memory rather than completely 
disrupting it. 
The rats’ postoperative memory was tested by ﬁ  rst placing 
them in the pool with the platform hidden: as expected, the 
lesioned rats couldn’t remember where it was. After a minute, 
the platform was raised above the water, to remind them 
that it existed and that they could escape by climbing onto it. 
The platform was revealed in the original location for half the 
animals and in a novel location—which could be construed 
as misleading information if you’re a rat—for the other half. If 
raising the platform was facilitating re-learning, then animals 
capable of learning would look for the platform in the new 
location. But if raising the platform functioned as a reminder, 
then animals should gravitate toward the place they were 
trained to, regardless of whether the platform reminder was in 
the original location or a new one. And that’s what happened to 
the rats with partial lesions. 
De Hoz et al. then repeated the experiments in a new 
environment. If the rats managed to escape in this situation, the 
authors explain, then the reminder treatment could be causing 
new learning rather than triggering recall of the original training 
experience. Not surprisingly, the rats with total lesions failed to 
learn in this new environment (or to be reminded in the previous 
experiment), while the control rats adapted to the new location. 
The group with partial lesions failed to learn. 
Since partially lesioned rats responded to the reminder 
treatment by recalling the original platform location, their initial 
memory failure couldn’t have resulted from a storage failure. 
And since they did not realize they could escape from the new 
location, the reminder didn’t induce new learning. Among the 
many questions these results raise is what role the hippocampus 
plays in memory storage and retrieval. It could be, as the authors 
propose, that essential components of spatial memory traces 
are either stored in the hippocampus or reactivated there, since 
only the partially lesioned rats responded to reminders. Whether 
that proves true, de Hoz et al. have contributed a much needed 
resource for investigating the neural basis of memory loss.
de Hoz L, Martin SJ, Morris RGM (2004) Forgetting, reminding, and 
remembering: The retrieval of lost spatial memory. DOI: 10.1371/
journal.pbio.0020225 
DOI: 10.1371/journal.pbio.0020283.g001
Rats given partial hippocampal lesions after training in a watermaze are 
initially unable to remember the location of the escape platform. 